May 9, 2023
Espoo, Finland. Euformatics, a Finnish bioinformatics company that develops world-leading NGS interpretation and quality control tools, has announced a distribution partnership with Zahrawi Group, a regional distributor in the Gulf area for, Surgical, Medical, Nuclear Medicine, Diagnostic, Analytical Lab, consumables and software. The agreement covers the markets of Bahrain, Oman and United Arab Emirates (UAE) [...]
Biosynth Further Strengthens Peptide Business with Acquisition of Cambridge Research Biochemicals.
May 9, 2023
Addition of UK based peptide and antibody production facilities expands peptides and biologics business in UK and Europe. Staad– Biosynth, a supplier of critical raw materials to the life science industry, announces today that it has acquired Cambridge Research Biochemicals (“CRB”), a leading independent producer of custom-made peptide and antibody tools, based in the UK [...]
EVOSEP AND CELLENION ENTER CO-MARKETING AGREEMENT TO BOOST SINGLE CELL PROTEOMICS
May 9, 2023
Making clinical proteomics 100x more robust and 10x faster Today at AOHUPO in Singapore – Evosep is pleased to announce a new co-marketing partnership with Cellenion. This partnership will enable researchers to access a complete solution for single-cell proteomics, combining Evosep's cutting-edge liquid chromatography technology with Cellenion's advanced single-cell isolation and sample preparation platform. Single-cell [...]
Quantoom Biosciences expands U.S. Market Reach with Key Appointments
May 8, 2023
Quantoom Biosciences S.A. (“Quantoom”), a Univercells company, is establishing a team in the United States. The company has appointed Oladimeji Fashola as Chief Technology Officer, and Business Development team of three. These crucial additions mark an exciting phase of growth for the company and underline its commitment to expanding its presence in the U.S. market. The fast [...]
May 8, 2023
BILLERICA, Mass. -- Bruker Corporation (Nasdaq: BRKR) today announced that is has closed the acquisition of ZONTAL Inc. (www.zontal.io), an innovative platform provider for the digital transformation of the analytical laboratory, and for integrated biopharma technical data solutions. This acquisition further strengthens Bruker BioSpin’s Integrated Data Solutions (IDS) software division, which includes Mestrelab Research (www.mestrelab.com), Arxspan (www.arxspan.com) and Optimal (www.optimal-ltd.co.uk). The ZONTAL acquisition [...]
MGI Launches Overseas Production Line of DNBSEQ-400* Sequencer in Latvia
May 8, 2023
Riga, Latvia – LATVIA MGI TECH, SIA, ("MGI Latvia”) a subsidiary of MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, today announced the official opening of its large-scale production line at Latvia. As MGI's largest regional hub for the European market, the facility based in Riga [...]
Flagship Acquires Managed Lab Services, Diversifies Its Biotech Portfolio
May 8, 2023
Flagship Facility Services is pleased to announce its acquisition of Managed Lab Services (MLS) – a leading lab services company headquartered in San Diego, California. MLS delivers cutting-edge laboratory support solutions to keep labs operating optimally. The company’s primary services include vendor-managed inventory, lab support, project management, and IT operations. MLS deploys a combination of highly [...]
Changes in Merck Executive Board
May 8, 2023
Marcus Kuhnert will step down as Chief Financial Officer and Member of the Executive Board after a successful nine-year tenure Helene von Roeder appointed Chief Financial Officer and Executive Board Member, effective July 1, 2023 Darmstadt, Germany – Marcus Kuhnert has decided to step down as Chief Financial Officer and Member of the Executive Board [...]
Changes in Nanologica’s Group Structure and Management Team for Full Focus on Chromatography
May 8, 2023
Nanologica AB (publ) has decided to focus on Chromatography and the management team is adapted to reflect the new business focus. In order to create the best conditions for success in preparative chromatography, the company's operations are focused on Chromatography and the Drug Development operations are down-prioritized and placed in subsidiaries for future opportunities. The [...]
May 8, 2023
Updated Microservices and Front End Architectures Deliver Vastly Improved Performance and User Experience, while ML-ready Data Fuel Biomarker Discovery via ResponderID Boston – Genialis, a computational precision medicine company unraveling complex biology to find new ways to treat disease, today released Genialis(™) Expressions version 3.0 to accelerate translational and clinical biomarker discovery. Expressions is a platform [...]

